Awadallah, C.; Zayad, A.; Atrash, S.; Mazloom, A.; Alkharabsheh, O.; Mewawalla, P.; Shah, M.R.; Lutfi, F.; Mahmoudjafari, Z.; Umair Mushtaq, M.;
et al. High-Risk Cytogenetic Multiple Myeloma Remains a Therapeutic Challenge: A 15-Year Real-World Analysis. Curr. Oncol. 2026, 33, 249.
https://doi.org/10.3390/curroncol33050249
AMA Style
Awadallah C, Zayad A, Atrash S, Mazloom A, Alkharabsheh O, Mewawalla P, Shah MR, Lutfi F, Mahmoudjafari Z, Umair Mushtaq M,
et al. High-Risk Cytogenetic Multiple Myeloma Remains a Therapeutic Challenge: A 15-Year Real-World Analysis. Current Oncology. 2026; 33(5):249.
https://doi.org/10.3390/curroncol33050249
Chicago/Turabian Style
Awadallah, Carmel, Anas Zayad, Shebli Atrash, Anita Mazloom, Omar Alkharabsheh, Prerna Mewawalla, Mansi R. Shah, Forat Lutfi, Zahra Mahmoudjafari, Muhammad Umair Mushtaq,
and et al. 2026. "High-Risk Cytogenetic Multiple Myeloma Remains a Therapeutic Challenge: A 15-Year Real-World Analysis" Current Oncology 33, no. 5: 249.
https://doi.org/10.3390/curroncol33050249
APA Style
Awadallah, C., Zayad, A., Atrash, S., Mazloom, A., Alkharabsheh, O., Mewawalla, P., Shah, M. R., Lutfi, F., Mahmoudjafari, Z., Umair Mushtaq, M., Kort, J., Habib, A., & Abdallah, A.-O.
(2026). High-Risk Cytogenetic Multiple Myeloma Remains a Therapeutic Challenge: A 15-Year Real-World Analysis. Current Oncology, 33(5), 249.
https://doi.org/10.3390/curroncol33050249
